OneProjects receives funding for cardiac imaging system development

The funding will support the development, clinic trials and commercial launch of OneProjects’s cardiac imaging system Verafeye. Credit: Mikael Häggström.

Irish-German medical device start-up OneProjects has raised $12m in a Series A financing round led by Dutch investment company LSP and the Atlantic Bridge University Fund.

Free Report

What’s missing from your IPO industry assessment?

IPO activity all but stopped in 2020, as the investment community grew wary of the effects of COVID-19 on economies. No matter how deserving a business was of flotation, momentum was halted by concerns of when a ‘new normal’ of working patterns and trade would set in. Recently, sentiment has changed. Flotations picked up again during the second half of 2021, and now in 2022 the mood is decidedly optimistic. Business leaders have their eyes on fast rebounding economies, buoyant market indices and the opportunity once again to take their businesses public. As a result, global IPOs are expected to hit back this year. With GlobalData’s new whitepaper, ‘IPOs in Consumer and Retail: 5 must-include elements for your prospectus industry report’, you can explore exactly what is needed in the essential literature. GlobalData’s focus lies in the critical areas to get right:

Macroeconomic and demographic environment
Consumer context
Industry environment
Competitive environment
Route to market

Interested to learn more about what to include in your IPO Industry Assessment report? Download our free whitepaper.

By GlobalData

By downloading this case study, you acknowledge that GlobalData may share your information with GlobalData and that your personal data will be used as described in their Privacy Policy Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Enterprise Ireland and a number of prominent MedTech entrepreneurs also participated in the financing round.

The company intends to use the fund to advance its product development and launch clinical trials.

It will also support the market launch of Verafeye, a connected platform technology developed by the company for the treatment of atrial fibrillation (AFib) and cardiac arrhythmias.

Verafeye technology offers 4D data from within the heart, increasing the efficacy and safety of AFib treatment.

Furthermore, it is expected to improve outcomes for patients while reducing the cost to the healthcare system.

OneProjects CEO Fionn Lahart said: “This investment will help us to further build our team in Dublin and Munich, advance product development and, ultimately, achieve our goal of helping physicians provide far better treatment for patients, suffering from AFib.”

OneProjects was founded in 2017 by Fionn Lahart and chief technology officer (CTO) Christoph Hennersperger. The company focuses on developing the treatment of cardiac arrhythmias, including AFib.

The disease, which often causes strokes and other heart conditions, affects more than 38 million people worldwide.

According to the American Heart Association, at least 2.7 million Americans are currently living with AFib.

If left untreated, atrial fibrillation is likely to double the risk of heart-related deaths. It is also said to be associated with a five-fold increased risk of stroke.